LONDON, May 7, 2015 /PRNewswire/ — Phosphate Therapeutics Limited (“Phosphate Therapeutics”), a development-stage specialty pharmaceuticals company, today announces positive results from the PEACH pivotal study of PT20 in subjects with hyperphosphataemia related to dialysis dependent chronic kidney disease (DD-CKD). PT20, invented in the UK by leading Cambridge-based scientists and exclusively licensed by Phosphate Therapeutics, is […]

SAN FRANCISCO, May 7, 2015 /PRNewswire/ — Iodine, an online resource combining the latest medical research on medications with real-life experiences from consumers, launched a new month-long study on May 1 to track people’s experiences while taking antidepressant medications. More than 30 million Americans currently take antidepressants, yet the largest study conducted to-date included just 4,041 […]

(Reuters) – Swiss drugmaker Roche said on Thursday the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for venetoclax for the treatment of people who have relapsed or refractory chronic lymphocytic leukemia with a genetic abnormality. “We are pleased that the FDA has granted venetoclax breakthrough therapy designation and hope this regulatory […]

A diabetic tests his blood sugar level in Vienna November 13, 2012. Picture taken November 13. Reuters/Heinz-Peter Bader (Reuters Health) – Intensive medical management with supervised diet and exercise may work as well as weight-loss surgery to help diabetics get blood sugar levels under control, at least in the short term, a small study suggests. […]

(Reuters) – The measles vaccine provides benefits beyond merely protecting against that highly contagious viral respiratory disease that remains a leading childhood killer in parts of the world, scientists say. By blocking the measles infection, the vaccine prevents measles-induced immune system damage that makes children much more vulnerable to numerous other infectious diseases for two […]

  LONDON (Thomson Reuters Foundation) – Fake and low-quality drugs hinder efforts to tackle disease, weaken public trust in national health systems and raise questions over governance, drug researchers said on Thursday. The proliferation of drugs which fail to work properly creates a “spiral of distrust” that undermines the legitimacy of public health systems, especially […]

SAN DIEGO, May 7, 2015 /PRNewswire/ — After two years, patients treated with orbital atherectomy, a device that sands away severely calcified plaque in the coronary arteries prior to stenting, continued to show positive results, according to new data from the ORBIT II trial presented today as a late-breaking clinical trial at the Society for Cardiovascular […]

SAN DIEGO, May 7, 2015 /PRNewswire/ — Treating both low-density lipoprotein (LDL), or “bad,” cholesterol with statins and blood pressure with calcium channel antagonists reduces harmful coronary plaque, according to a new study presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions in San Diego. The […]

Conference Call and Webcast Today, May 7, 2015 at 4:30 p.m. Eastern Time ANN ARBOR, MI–(Marketwired – May 07, 2015) – Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today provided […]

SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced a reprioritization of its product development programs. As a result of this reprioritization, La Jolla will discontinue development of its polysaccharide-based […]